Nanocarriers for the effective treatment of cervical cancer: Research advancements and patent analysis

K Pathak, N Akhtar - Recent Patents on Drug Delivery & …, 2018 - ingentaconnect.com
Background: Cervical cancer being the cancer of cervix is caused by an aberrant cell growth
that acquires an ability to spread/invade to other body parts. It has also been reported to be …

Targeted drug delivery in cervical cancer: Current perspectives

S Ghosh, P Jayaram, SP Kabekkodu… - European Journal of …, 2022 - Elsevier
Cervical cancer is preventable yet one of the most prevalent cancers among women around
the globe. Though regular screening has resulted in the decline in incidence, the disease …

Nanotechnology-based drug delivery systems for the treatment of cervical cancer: A comprehensive review

M Singhai, G Das Gupta, B Khurana… - Current …, 2024 - ingentaconnect.com
Background: Cancer is a global public health issue; in the United States, it is the second
leading cause of death. Furthermore, cancer, which consists of distinct subtypes of cancer …

Possible role of nanocarriers in drug delivery against cervical cancer

S Gupta, MK Gupta - Nano reviews & experiments, 2017 - Taylor & Francis
Introduction: Cervical cancer is the second most common cancer and the largest cancer
killer among women in most developing countries including India. Although, various drugs …

Update on the use of nanocarriers and drug delivery systems and future directions in cervical cancer

LM Himiniuc, BF Toma, R Popovici… - Journal of …, 2022 - Wiley Online Library
Cervical cancer represents a major health problem among females due to its increased
mortality rate. The conventional therapies are very aggressive and unsatisfactory when it …

Development of drug targeting and delivery in cervical cancer

U Aggarwal, AK Goyal, G Rath - Current Cancer Drug Targets, 2018 - ingentaconnect.com
Cervical cancer is the second most common cancer in women. Standard treatment options
available for cervical cancer include chemotherapy, surgery and radiation therapy …

A recent advancement in nanotechnology approaches for the treatment of cervical cancer

YM Hegde, P Theivendren, G Srinivas… - Anti-Cancer Agents …, 2023 - ingentaconnect.com
Background: Cervical cancer is one of the leading causes of female death, with a mortality
rate of over 200,000 per year in developing countries. Despite a decrease in cervical cancer …

Highlights in nanocarriers for the treatment against cervical cancer

KP Medina-Alarcón, AR Voltan… - Materials Science and …, 2017 - Elsevier
Cervical cancer is the second most common malignant tumor in women worldwide and has
a high mortality rate, especially when it is associated with human papillomavirus (HPV). In …

Colloidal nanocarriers as versatile targeted delivery systems for cervical cancer

A Sugumaran, V Mathialagan - Current Pharmaceutical Design, 2020 - ingentaconnect.com
Background: The second most common malignant cancer of the uterus is cervical cancer,
which is present worldwide, has a rising death rate and is predominant in developing …

Cervical Cancer: Novel Treatment Strategies Offer Renewed Optimism

G Srinivasan - Pathology-Research and Practice, 2024 - Elsevier
Cervical cancer poses a significant global public health issue, primarily affecting women,
and stands as one of the four most prevalent cancers affecting woman globally, which …